arrow
T

Takumi Imai

organization for clinical medicine promotion
H指数:17
被引数:1,562

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sacubitril/valsartan and cardiac injury/stress and systemic inflammatory biomarkers in acute heart failure: a pre-specified secondary analysis of the PREMIER study

沙库巴曲/缬沙坦及心脏损伤/应激和全身性炎症生物标志物在急性心力衰竭中的作用:PREMIER研究的预先指定二次分析

2026-09-110
OAAI
Four-year neurodevelopmental outcomes in infants with symptomatic congenital cytomegalovirus disease treated with oral valganciclovir: A prospective follow-up study in Japan

口服缬更昔洛韦治疗有症状先天性巨细胞病毒疾病的婴儿的四年神经发育结局:一项日本前瞻性随访研究

2026-06-010
PRE
Personalized exercise therapy during targeted drug therapy tapering in patients with rheumatoid arthritis: a pilot randomized controlled trial

类风湿关节炎患者靶向药物治疗减量期间个性化运动疗法的疗效:一项试点随机对照试验

2026-05-130
PRE
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)

非奈利酮对动脉僵硬度及心肾生物标志物的影响:一项随机、安慰剂对照机制性试验(FIVE-STAR)

2025-12-050
OAAI
Impact of early in-hospital initiation of sacubitril/valsartan on left ventricular reverse remodelling in acute heart failure

早期院内沙库巴曲/缬沙坦启动对急性心力衰竭患者左心室逆转重构的影响

2025-08-012
OAAI
Three-year hearing outcomes in infants with congenital cytomegalovirus disease treated with oral valganciclovir: Interim results of a six-year follow-up study in Japan

口服缬更昔洛韦治疗先天性巨细胞病毒疾病婴儿的三年听力结果: 日本六年随访研究的中期结果

2025-03-010
PRE
Immune Response to an Adjuvanted Recombinant Zoster Vaccine in Japanese Patients with Rheumatoid Arthritis Receiving Upadacitinib (End Zoster-J Study): Study Protocol for an Exploratory Parallel Triple-Arm Prospective Trial

接受Upadacitinib的日本类风湿关节炎患者对佐剂重组带状疱疹疫苗的免疫反应 (End zoster-j研究): 探索性平行三臂前瞻性试验的研究方案

2024-12-020
OAAI
In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trial

在医院内启动血管紧张素受体-脑啡肽酶抑制急性心力衰竭: 首要试验

2024-08-313
OAAI